Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Almac Group
Craigavon, Northern Ireland, United Kingdomalmacgroup.com ↗
- Ownership
- Private
- Employees
- ~7700
- Development stage
- Commercial
01
Overview
Provides integrated services across the drug development lifecycle. Contributed to over half of FDA-approved NMEs in recent years. No direct clinical results as it is a service provider rather than a therapeutic developer.
- Therapeutic areas
- OncologyPulmonologyImmunologyGastroenterologyNeurology
- Modalities
- Small moleculesPeptides/proteinsBiomarkers/companion diagnostics
- Industry
- Contract Research Organization
02
Partnerships
Recent partnership with Future Medicines Institute.Key licensing agreement with Formosa Pharmaceuticals for ALM‑401 development/commercialization.Numerous partnerships with global biopharma companies as contract clients.
Beyond the preview
Go deeper on Almac Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Almac Group.